한글목차

CRISPR 및 CAS 유전자 시장은 2025년에는 23억 2,000만 달러로 추정되며, 2032년에는 97억 7,000만 달러에 달할 것으로 예측되며, 2025-2032년까지 연평균 성장률(CAGR) 22.8%로 성장할 전망입니다.

Clustered regularly interspaced short palindromic repeats(CRISPR)-Cas9은 유전학자와 의료 연구자들이 데옥시리보핵산(DNA) 서열의 일부를 제거, 추가, 변경하여 유전체의 일부를 편집할 수 있도록 하는 독특한 기술입니다. CRISPR-Cas9 시스템은 DNA에 돌연변이를 도입하는 두 가지 주요 분자로 구성되어 있습니다. 하나는 Cas9이라는 효소입니다. 이것은 유전체의 특정 위치에서 DNA의 두 가닥을 절단하는 '분자 가위'의 역할을 합니다. 두 번째 구성요소는 가이드 RNA(gRNA)라고 불리는 것입니다. 이것은 긴 RNA 스캐폴드 안에 미리 설계된 작은 RNA 서열(약 20 염기 길이)로 구성되어 있습니다. 골격 부분은 DNA와 결합하고, 미리 설계된 서열이 Cas9을 유전체의 적절한 부분으로 '유도'합니다. 이를 통해 Cas9 효소는 유전체의 적절한 부분에서 절단됩니다.

시장 역학

주요 업체들은 유전성 질환을 위해 CRISPR, CAS 유전자 등 다양한 치료법을 개발하고 있습니다. 예를 들어, 2016년 미국에 본사를 둔 Addgene은 헌팅턴병 치료를 위한 중추신경계(CNS) 질환 유전자 편집을 위한 '자가 비활성화' KamiCas9 시스템을 포함한 CRISPR-Cas9의 버전인 KamiCas9를 개발했습니다.

CRISPR 기술은 당뇨병, 암 등의 치료법 개발에 널리 사용되고 있습니다. 따라서 이러한 질병의 유병률 증가는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 국제당뇨병연맹에 따르면 2019년 약 4억 6,300만 명의 성인(20-79세)이 당뇨병을 앓고 있으며, 2045년에는 전 세계적으로 7억 명으로 증가할 것으로 예상됩니다. 또한 65세 이상 인구 5명 중 1명이 당뇨병을 앓고 있습니다.

또한 세계보건기구(WHO)의 데이터 조사 결과에 따르면, 2018년 2월 암은 세계 2위의 사망원인이며, 암으로 인해 약 1,810만 명의 신규 환자와 960만 명의 사망자가 등록되었습니다. 암으로 인한 사망의 약 70%는 중저소득 국가에서 발생하고 있으며, 전 세계 사망자 중 약 6명 중 1명이 암으로 인해 사망한 것으로 나타났습니다.

본 조사의 주요 특징

• 이 보고서는 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 전 세계 CRISPR 및 CAS 유전자 시장을 상세히 분석하여 시장 규모를 예측한 보고서입니다.
• 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 지리적 입지, 유통 전략, 주요 개발 및 전략, 미래 계획 등의 매개 변수를 기반으로 세계 CRISPR 및 CAS 유전자 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 개선, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 CRISPR 및 CAS 유전자 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 CRISPR 및 CAS 유전자 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 합병, 인수, 협업
• 규제 시나리오
• PEST 분석
• Porters 분석

제4장 세계의 CRISPR 및 CAS 유전자 시장, 제품 유형별, 2020-2032년

• 소개
• 벡터 기반 CAS
• DNA 프리 CAS
• 기타

제5장 세계의 CRISPR 및 CAS 유전자 시장, 용도별, 2020-2032년

• 소개
• 유전체 공학
• 질환 모델
• 기능유전체학
• 넉다운/활성화
• 기타

제6장 세계의 CRISPR 및 CAS 유전자 시장, 최종사용자별, 2020-2032년

• 소개
• 바이오테크놀러지와 제약회사
• 학술기관과 정부 연구기관
• 계약 연구기관

제7장 세계의 CRISPR 및 CAS 유전자 시장, 지역별, 2020-2032년

• 소개
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN 국가
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제8장 경쟁 구도

• 기업 개요
  • Thermo Fisher Scientific Inc.
  • Merck KGaA(Sigma-Aldrich)
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Cellecta, Inc.
  • Agilent Technologies
  • Applied StemCell, Inc.
  • Synthego
  • Genscript
  • Mirus Bio LLC
  • Integrated DNA Technologies, Inc.
  • Mammoth Biosciences, Inc.

제9장 섹션

• 참고문헌
• 조사 방법

영문목차

Crispr And Cas Gene Market is estimated to be valued at USD 2.32 Bn in 2025 and is expected to reach USD 9.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a unique technology that enables the geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the deoxyribonucleic acids (DNA) sequence. The CRISPR-Cas9 system consists of two key molecules that introduce a mutation into the DNA. The first component is an enzyme, which is called as Cas9. This acts as a pair of 'molecular scissors' that can cut the two strands of DNA at a specific location in the genome so that bits of DNA can then be added or removed. The second component is called guide RNA (gRNA). This consists of a small piece of pre-designed RNA sequence (about 20 bases long) located within a longer RNA scaffold. The scaffold part binds to DNA and the pre-designed sequence 'guides' Cas9 to the right part of the genome. This makes sure that the Cas9 enzyme cuts at the right point in the genome.

Market Dynamics

Key players are developing various treatment options, such as CRISPR and CAS genes, for genetic diseases. For instance, in 2016, the U.S.-based company, Addgene, developed the KamiCas9, a version of CRISPR-Cas9 that includes a 'self-inactivating' KamiCas9 system for the editing of central nervous system (CNS) disease genes for the treatment of Huntington's disease.

CRISPR technology is widely used to develop therapeutics for diseases such as diabetes, cancer, etc. Hence, the increasing prevalence of such diseases is expected to drive the market growth over the forecast period. According to The International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years of age) were living with diabetes; by 2045, this will increase to 700 million worldwide. Moreover, one in five of the people who are above 65 years old have diabetes.

Furthermore, according to data findings by the World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% of deaths from cancer occurred in low and middle income countries, and around one in six deaths across the globe were caused by cancer.

Key features of the study:

• This report provides an in-depth analysis of global CRISPR and CAS gene market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global CRISPR and CAS gene market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global CRISPR and CAS gene market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the CRISPR and CAS gene market

Detailed Segmentation:

• Global CRISPR and CAS Gene Market, By Product Type:
  • Vector-based CAS
  • DNA-free CAS
  • Others
• Global CRISPR and CAS Gene Market, By Application:
  • Genome Engineering
  • Disease Models
  • Functional Genomics
  • Knockdown/Activation
  • Others
• Global CRISPR and CAS Gene Market, By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
• Global CRISPR and CAS Gene Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Sigma-Aldrich)
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Synthego
  • Genscript
  • Mirus Bio LLC
  • Integrated DNA Technologies, Inc.
  • Mammoth Biosciences, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Recent Trends
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis
• PORTER's Analysis

4. Global Crispr And Cas Gene Market, By Product Type, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Vector-based Cas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• DNA-free Cas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends

5. Global Crispr And Cas Gene Market, By Application, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Genome Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Disease Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Functional Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Knockdown/Activation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends

6. Global Crispr And Cas Gene Market, By End User, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Academic & Government Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Crispr And Cas Gene Market, By Region, 2020 - 2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• North America
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Merck KGaA (Sigma-Aldrich)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • OriGene Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • New England Biolabs
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Cellecta, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Applied StemCell, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Synthego
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Genscript
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mirus Bio LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Integrated DNA Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mammoth Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
    • Analysts' Views

9. Section

• References
• Research Methodology
• About us and Sales Contact